Afamelanotide
Scenesse, Melanotan I, Melanotan-1, MT-1, CUV1647, NDP-MSH
A synthetic alpha-MSH analogue approved as an implant for one rare light disease in adults. Melanotan I was a code name; products sold as it are not the drug.
Peptides studied for skin and hair, keeping topical cosmetic research separate from systemic claims, which are two different literatures.
Dermatology research on peptides splits into two very different literatures: topical cosmetic studies, which are often small and industry-funded, and systemic research, which is sparser. Conflating them is the most common error in this area.
Scenesse, Melanotan I, Melanotan-1, MT-1, CUV1647, NDP-MSH
A synthetic alpha-MSH analogue approved as an implant for one rare light disease in adults. Melanotan I was a code name; products sold as it are not the drug.
copper tripeptide-1, GHK copper, prezatide copper, glycyl-L-histidyl-L-lysine copper
A three-amino-acid peptide bound to copper, used in skin care. Its human studies are topical; none injected GHK-Cu on its own or tested it systemically.
Melanotan 2, Melanotan-II, MT-II, MTII, MT2
A synthetic cyclic peptide sold for tanning. Its human trials total 23 men between 1996 and 2000, and none of the regulators checked has approved it.
Safety
No regulator checked has approved Melanotan II. What authorities in the US, UK, Australia, Ireland, Denmark, Canada and Norway say about selling it.
Comparison
GHK-Cu on skin has a small, old, mostly null human record. No human study of it alone by injection was found. What each route rests on.